Seven Ohio oncologists were charged with importing cancer medications that had not been approved by the Federal Drug Administration, said U.S. Attorney Steven M. Dettelbach.
The doctors were charged with causing the shipment of misbranded drugs, a misdemeanor violation of the Food, Drug and Cosmetic Act.
Their names, ages and the city where they practiced medicine are:
- Ranjan Bhandari, 56, Liverpool
- Timmappa Bidari, 68, Parma
- David Fishman, 62, Euclid
- Su-Chiao Kuo, 60, Brunswick
- Marwan Massouh, 54, Westlake
- Poornanand Palaparty, 62, Cleveland
- Hassan Tahsildar, 55, Euclid
"These doctors used drugs that had not been approved by the FDA," Dettelbach said. "Our office is committed to working with our partners to make sure patients are getting medicine that has been properly inspected."
The doctors are accused of obtaining drugs, including Zometa, Kytril, Taxotere, Gemzar, Eloxatin and others, from outside the United States, where the drugs were not approved by the FDA, according to the charges.
A drug may be considered misbranded even if it is identical in composition to an FDA-approved drug (that is, a drug labeled and packaged in compliance with the FDA's standards) and even if it was made by the same manufacturer in the same facility as the FDA-approved version.
If convicted, the doctors face up to one year in prison and fines up to $100,000.